Resources>Citations Database>Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Biointron 2025-08-07

Authors: Uday Chintapula, Shujing Liu, Andres Fernandez Del Castillo, Jianhua Lim, Yoonho Roh, Shrawan Kumar Mageswaran, Xiaogang Zhang, Renee-Tyler T. Morales, Mark A. Sellmyer, Yi-Wei Chang, Xiaowei Xu, Jina Ko

Journal: Small

PubMed ID: 40772393

DOI: https://doi.org/10.1002/smll.202503807

Products & Services: Anti-DR5 monoclonal antibodies (tigatuzumab) were manufactured by Biointron Biological


Share:
Subscribe to our Citations Database
Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma

MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IR……

Nov 25, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.